Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manuel Hidalgo

Showing results (51-60 of 384) with videos related to

Pageof 39
Sort By:
Nature Reviews. Clinical Oncology|November 10, 2019
From state-of-the-art treatments to novel therapies for advanced-stage pancreatic cancerChristopher Nevala-Plagemann, Manuel Hidalgo, Ignacio Garrido-Laguna
Hematology/Oncology Clinics of North America|January 7, 2003
Development of matrix metalloproteinase inhibitors in cancer therapyW Thomas Purcell, Michelle A Rudek, Manuel Hidalgo
Cirugia Espanola|March 1, 2011
[Surgical management of familial colorectal cancer type X]Irene Osorio, Manuel Lomas, Manuel Hidalgo, et al.
Revista Espanola De Enfermedades Digestivas|September 29, 2011
Liver hydatidosis in the present decadeManuel Hidalgo, Eduardo Ferrero, José Perea, et al.
Clinical Lung Cancer|September 15, 2005
Current status of mammalian target of rapamycin inhibitors in lung cancerCarlos Gómez-Martín, Belen Rubio-Viqueira, Manuel Hidalgo
Animals : an Open Access Journal From MDPI|September 9, 2023
Selection and Conservation of Gametes and Embryos for Improving Assisted Reproductive TechnologiesAndrés Gambini, Isabel Ortiz, Manuel Hidalgo, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 9, 2011
SEOM clinical guidelines for the treatment of pancreatic cancerCarlos Gómez-Martín, Manuel Hidalgo, Josep Tabernero, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 26, 2021
Reply to K. de Joode et alGagandeep Brar, Laura C Pinheiro, Manuel Hidalgo, et al.
Clinical Advances in Hematology & Oncology : H&O|December 5, 2006
Novel targets in solid tumors: MEK inhibitorsWells A Messersmith, Manuel Hidalgo, Michael Carducci, et al.
Cirugia Espanola|March 26, 2010
[Influence of age on the surgical treatment of lynch syndrome]Edurne Alvaro, José Perea, Manuel Lomas, et al.
Pageof 39

Showing results (51-60 of 384) with videos related to

Sort By:
Pageof 39
Nature Reviews. Clinical Oncology|November 10, 2019
From state-of-the-art treatments to novel therapies for advanced-stage pancreatic cancerChristopher Nevala-Plagemann, Manuel Hidalgo, Ignacio Garrido-Laguna
Hematology/Oncology Clinics of North America|January 7, 2003
Development of matrix metalloproteinase inhibitors in cancer therapyW Thomas Purcell, Michelle A Rudek, Manuel Hidalgo
Cirugia Espanola|March 1, 2011
[Surgical management of familial colorectal cancer type X]Irene Osorio, Manuel Lomas, Manuel Hidalgo, et al.
Revista Espanola De Enfermedades Digestivas|September 29, 2011
Liver hydatidosis in the present decadeManuel Hidalgo, Eduardo Ferrero, José Perea, et al.
Clinical Lung Cancer|September 15, 2005
Current status of mammalian target of rapamycin inhibitors in lung cancerCarlos Gómez-Martín, Belen Rubio-Viqueira, Manuel Hidalgo
Animals : an Open Access Journal From MDPI|September 9, 2023
Selection and Conservation of Gametes and Embryos for Improving Assisted Reproductive TechnologiesAndrés Gambini, Isabel Ortiz, Manuel Hidalgo, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 9, 2011
SEOM clinical guidelines for the treatment of pancreatic cancerCarlos Gómez-Martín, Manuel Hidalgo, Josep Tabernero, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 26, 2021
Reply to K. de Joode et alGagandeep Brar, Laura C Pinheiro, Manuel Hidalgo, et al.
Clinical Advances in Hematology & Oncology : H&O|December 5, 2006
Novel targets in solid tumors: MEK inhibitorsWells A Messersmith, Manuel Hidalgo, Michael Carducci, et al.
Cirugia Espanola|March 26, 2010
[Influence of age on the surgical treatment of lynch syndrome]Edurne Alvaro, José Perea, Manuel Lomas, et al.
Pageof 39